The experiments in this project propose to examine the development of the positively reinforcing properties of abused drugs. Two paradigms that are well established in the adult literature and are believed to assess drug abuse potential will be used. These are the conditioned place preference and intracranial electrical self-stimulation paradigms (ICSS). Because of the large literature suggestive of a critical role of the mesolimbic dopamine system in drug abuse and in these two paradigms, the proposed experiments concentrate on the ventral tegmental area of the midbrain (VTA). The effects of morphine and cocaine will be tested in these two paradigms: we will test that ability of these drugs to enhance ICSS responding to stimulation by a VTA located electrode and to support place preference conditioning when injected directly into the VTA. These experiments will determine the development of the reinforcing properties of these two abused drugs and will provide a developmental time frame for in vivo dialysis studies of the effects of these drugs on mesolimbic dopamine function. In a second series of experiments, the effects of early postnatal exposure to morphine and cocaine will be tested in three models of drug abuse vulnerability. The first two are the conditioned place preference and ICSS as described above and the third is self-administration of abused drugs.. Rats dosed chronically during infancy will be tested in these three models; in addition, subjects treated both in infancy and adulthood will be tested. These experiments are unique in that there are no data that speak to the issue of the long term consequences of early perinatal exposure to drugs, despite the large and growing numbers of human infants who have been so exposed. In addition, these treatments serve as independent variables for testing the hypothesis that the action of abused drugs is mediated through the mesolimbic dopamine system. Biochemical studies of in vivo dopamine release and opioid and dopamine receptor autoradiography will pinpoint neurochemical differences caused by the neonatal drug exposure that do or do not correlate with the increased drug abuse vulnerability. The studies therefore provide new and important information about the development of the reinforcing properties of morphine and cocaine, the long term consequences for brain reward mechanisms due to exposure to these drugs, and the neural mechanisms by which these.drugs produce their potent effects on neural systems related to reinforcement.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA006600-01
Application #
3213251
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1989-09-30
Project End
1992-08-31
Budget Start
1989-09-30
Budget End
1990-08-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
New York State Psychiatric Institute
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Barr, Gordon A; McPhie-Lalmansingh, Anika; Perez, Jessica et al. (2011) Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience. ILAR J 52:329-41
McPhie, Anika A; Barr, Gordon A (2009) Regional Fos expression induced by morphine withdrawal in the 7-day-old rat. Dev Psychobiol 51:544-52
Butkevich, Irina P; Barr, Gordon A; Vershinina, Elena A (2007) Sex differences in formalin-induced pain in prenatally stressed infant rats. Eur J Pain 11:888-94
Butkevich, I P; Barr, G A; Vershinina, E A (2007) [Sex-dependent differences in parameters of a long-term pain caused by inflammatory focus in prenatally stressed newborn rats] Zh Evol Biokhim Fiziol 43:54-9
Butkevich, Irina P; Barr, Gordon A; Mikhailenko, Victor A et al. (2006) Increased formalin-induced pain and expression of fos neurons in the lumbar spinal cord of prenatally stressed infant rats. Neurosci Lett 403:222-6
Zhu, Hongbo; Barr, Gordon A (2003) Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat. Pain 104:437-47
Jones, Kathy L; Zhu, Hongbo; Jenab, Shirzad et al. (2002) Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology 26:301-10
Jones, K L; Barr, G A (2001) Injections of an opioid antagonist into the locus coeruleus and periaqueductal gray but not the amygdala precipitates morphine withdrawal in the 7-day-old rat. Synapse 39:139-51
Zhu, H; Barr, G A (2001) Opiate withdrawal during development: are NMDA receptors indispensable? Trends Pharmacol Sci 22:404-8
Zhu, H; Barr, G A (2001) Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent. Synapse 40:282-93

Showing the most recent 10 out of 23 publications